Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$62.0K-56.92%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Gary L. Herman
- Sector
- Utilities
- Industry
- Renewable Utilities
- Employees
- 100
- Beta
- 0.76
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -47.90
Financials
Revenue
$62.0K-56.9%Net Income
$8.63MEBITDA
$8.80MFree Cash Flow
$287.0KEPS (diluted)
$2.92Shares Outstanding (diluted)
2.96M+9882.6%Operating Expenses
$2.20MCash & Debt
$468.0KReturn of Capital
$0.00Revenue by Segment (annual)
$3.28MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $3.28M | $-40.99M | $-11.46 |
| 2023 | $1.54M | $-71.40M | $-26.55 |
| 2022 | $7.84M | $-74.34M | $-43.28 |
| 2021 | $7.07M | $-20.52M | $-13.44 |
| 2020 | $882.7K | $-3.12M | $-4.56 |
| 2019 | $620.2K | $-358.3K | $-12.10 |
| 2018 | $373.7K | $-565.4K | $0.00 |
Valuation
ADNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+5.26%Social Signal Score
Mentions (5)
- Newsglobenewswire.com·34d ago·Neutral
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Adven
View source ↗ - Newspymnts.com·39d ago·Positive
Advent, Stripe Abandon $50 Billion Pursuit of PayPal The blockbuster PayPal buyout could be off. Advent International and Stripe have reportedly walked away from their pursuit of the payments pioneer, ending months of speculation over a deal that would have ranked among the largest leveraged buyouts ever.
View source ↗ - Newsreuters.com·39d ago·Positive
Advent, Stripe consortium is said to drop pursuit of PayPal, Bloomberg News reports A consortium of buyout firm Advent and payment processor Stripe has decided to abandon its pursuit of fintech pioneer PayPal , Bloomberg News reported on Thursday, citing people familiar with the matter.
View source ↗ - Newsglobenewswire.com·49d ago·Negative
BrewDog Unwraps Its 2026 Advent Calendar New brews, bold flavours and one unmissable 24-day countdown to Christmas New brews, bold flavours and one unmissable 24-day countdown to Christmas
View source ↗ - Newswsj.com·52d ago·Neutral
Stripe, Advent in Talks to Buy PayPal The fintech startup and private-equity firm Advent offered to buy the struggling payments company in July
View source ↗
Earnings
Typical surprise +12.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 20$-10.32 vs $-6.00miss
- Fri, Mar 29$-0.20 vs $-6.00beat
Estimates and results for ADN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ADN officers and directors.
No open-market trades in the recent filings. All 4 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
4 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ADN.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.